Walleye Capital LLC Global Blood Therapeutics, Inc. Put Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $175,224 - $366,240	-4,200 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $2 Million - $3.59 Million	-43,800 Reduced 91.25%	4,200 $334,000
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $1.71 Million - $2.18 Million	37,600 Added 361.54%	48,000 $2.33 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $310,340 - $373,411	5,900 Added 131.11%	10,400 $547,000
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $179,955 - $240,660	4,500 New	4,500 $238,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.